ARTICLE | Clinical News
Suboxone buprenorphine/naloxone sublingual film regulatory update
September 6, 2010 7:00 AM UTC
FDA approved an NDA from Reckitt's Reckitt Benckiser Pharmaceuticals Inc. subsidiary for Suboxone buprenorphine/naloxone sublingual film to treat opioid dependency. The approval includes a REMS to ens...